Who owns Ernexa Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Ernexa Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Ernexa Therapeutics stock

Who bought or sold Ernexa Therapeutics Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
CI Private Wealth 438k $526k 0% Dec 2025
 View chart
Vanguard Group 36k $43k 222% Dec 2025
 View chart
Geode Capital Management 24k $28k 15% Dec 2025
 View chart
Hrt Financial 13k $15k 100% Dec 2025
 View chart
Sippican Capital Adivsors 10k $12k 0% Dec 2025
 View chart
BlackRock 820.00 $984.000000 0% Dec 2025
 View chart
Fortitude Family Office 804.00 $964.960800 100% Dec 2025
 View chart
UBS Group 600.00 $720.000000 100% Dec 2025
 View chart
Assetmark 133.00 $159.999000 0% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 10.00 $12.000000 0% Dec 2025
 View chart
A. Montag and Associates 8.00 $10.000000 0% Dec 2025
 View chart
Activest Wealth Management 3.00 $3.999900 0% Dec 2025
 View chart

Who sold out of Ernexa Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Susquehanna International Sep 2025 31k $34k
Tower Research Capital Sep 2025 5.2k $5.7k
EverSource Wealth Advisors Sep 2025 116.00 $126.996800